Drug Research
Quadripartite launches a new platform to tackle antimicrobial resistance threat to human and animal health and ecosystems
The Antimicrobial Resistance Multi-Stakeholder Partnership Platform was launched to ensure the growing threats and impacts of antimicrobial resistance are addressed globally.
The Food and Agriculture Organization...
News
Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Booster in Adults
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Health Canada has granted expanded authorization for...
Drug Research
Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc. announced a collaboration and licensing agreement to create conditionally-activated investigational bispecific cancer therapies utilizing CytomX's Probody® therapeutic platform...
News
UPS Completes Acquisition of Bomi Group Multi-National Healthcare Logistics Firm
UPS announced that it has closed on the acquisition of Bomi Group, an industry-leading multi-national healthcare logistics provider. Through the acquisition, the company's healthcare unit,...
News
How Product Inspection Affects The Quality of Liquid Drugs
More than 143 million COVID-19 doses had been given in the UK as of the end of May 2022 since the start of this historic...
News
The Bacteria Causing Leprosy May Be Able To Repair Livers
Researchers have made a ground-breaking revelation: the parasites that cause leprosy can rewire cells to enlarge the liver.
According to the most recent study, it may...
Drug Research
Australia Offers A Nasal Vaccine To Guard Against COVID-19
Researchers from Australia's Centenary Institute and the University of Sydney have created a novel nasal vaccination system that promotes strong lung resistance and tolerance against...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.















